Expert Review of Clinical Immunology

SJR Rank #3,649H-index: 85SJR: 1.198Best quartile: Q2
Journal website: aims, scope and author guidelines
Publisher

Taylor and Francis Ltd.

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.30.60.91.2

Subject Categories

  • ImmunologyQ2
  • Immunology and AllergyQ2

Areas: Immunology and Microbiology · Medicine

Most published research topics

Asthma and respiratory diseasesSystemic Lupus Erythematosus ResearchRheumatoid Arthritis Research and TherapiesAllergic Rhinitis and SensitizationPsoriasis: Treatment and PathogenesisImmunodeficiency and Autoimmune DisordersAutoimmune and Inflammatory Disorders ResearchImmune Cell Function and InteractionDermatology and Skin DiseasesSpondyloarthritis Studies and Treatments

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs095190285380

Documents per Year

2022202503570105140

Detailed Information

ISSN

1744-666X, 1744-8409

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

4.07

References per Document

94.26

Coverage

2006-2026

Scope

Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology. Articles focus on the following key areas: • Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines • Performance and benefits of newly approved therapeutic agents • New diagnostic approaches • Screening and patient stratification • Pharmacoeconomic studies • New therapeutic indications for existing therapies • Adverse effects, occurrence and reduction • Prospects for medicines in late-stage trials approaching regulatory approval • Novel treatment strategies • Epidemiological studies • Commentary and comparison of treatment guidelines Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.

Metrics from SCImago Journal Rank 2025. View on SCImago